{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-22-001427","form_type":"8-K","ticker":"LCTC","cik":"0001493137","company_name":"Lifeloc Technologies, Inc","filed_at":"2022-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.836443+00:00","generated_at":"2026-06-21T19:58:25.310384+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lifeloc Q3 net loss $0.04/share vs profit $0.21 YoY; revenue up 8% but supply chain hurts","bullets":["Revenue $2.032M (+8% YoY); net loss $(87k) vs profit $523k in Q3 2021 (included $471k PPP forgiveness).","Nine months 2022: revenue $6.373M, net loss $(433k) or $(0.18)/share vs net profit $816k ($0.33) prior year.","R&D investment increases and supply chain disruption contribute to loss; broad price increase implemented Q2.","LX9 and LT7 L-series devices driving sales growth; expected to be incremental to FC line.","SpinDx marijuana detection testing shows good correlation; development continues; R&D spend to stay high."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-22-001427","json":"https://secwatch.observer/filing/0001079973-22-001427.json","markdown":"https://secwatch.observer/filing/0001079973-22-001427.md","text":"https://secwatch.observer/filing/0001079973-22-001427.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493137/000107997322001427/0001079973-22-001427-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493137/000107997322001427/lclc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T19:58:25.310384+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"05fb235be46947599462bd9dbe6fba3523664125","claim":"Lifeloc Technologies, Inc reported the quarter ended September 30, 2022 results: revenue $2.032 million, net income $(87) thousand, EPS $(0.04) per diluted share.","evidence_excerpt":"Lifeloc posted quarterly net revenue of $2.032 million in the third quarter of 2022, resulting in a quarterly net loss of $(87) thousand, or $(0.04) per diluted share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1493137/000107997322001427/0001079973-22-001427-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2022"},{"label":"Revenue","value":"$2.032 million"},{"label":"Net income","value":"$(87) thousand"},{"label":"EPS","value":"$(0.04) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"8936edd58e4cd041023368a05dafb53f5c1b7baf","claim":"Lifeloc Technologies, Inc reported the nine months ended September 30, 2022 results: revenue $6.373 million, net income $(433) thousand, EPS $(0.18) per diluted share.","evidence_excerpt":"Nine-month net revenue of $6.373 million and a net loss of $(433) thousand, or $(0.18) per diluted share, compared to net revenue of $5.427 million and a net profit of $816 thousand, or $0.33 per diluted share, for the same nine months of 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1493137/000107997322001427/0001079973-22-001427-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the nine months ended September 30, 2022"},{"label":"Revenue","value":"$6.373 million"},{"label":"Net income","value":"$(433) thousand"},{"label":"EPS","value":"$(0.18) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}